Bisoprolol Fumarate and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Bisoprolol Fumarate and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | bisoprolol fumarate and hydrochlorothiazide |
| SUBSTANCE NAME: | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2000-09-25 |
| END MARKETING DATE: | 0000-00-00 |
Bisoprolol Fumarate and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bisoprolol Fumarate and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 6.25(mg/1; mg/1) |
| START MARKETING DATE: | 2000-09-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-0501_fe98646b-ed32-4db4-8ef7-f0fda4ecd4db |
| PRODUCT NDC: | 0378-0501 |
| APPLICATION NUMBER: | ANDA075768 |
Other BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
